Gadobutrol

(Gadavist)

Gadobutrol

Drug updated on 11/9/2023

Dosage FormInjection (intravenous; 1 mmol/mL)
Drug ClassGadolinium-based contrast agents
Ongoing and Completed StudiesClinicalTrials.gov

Indication

  • Indicated for intravenous use in diagnostic MRI to detect and visualize areas with disrupted blood brain barrier (BBB) and/or abnormal vascularity of the central nervous system in adult and pediatric patients, including term neonates.
  • For the assessment of the presence and extent of malignant breast disease in adult Patients.
  • For the evaluation of known or suspected supra-aortic or renal artery disease in adult and pediatric patients, including term neonates.
  • For the assessment of myocardial perfusion (stress, rest) and late gadolinium enhancement in adult patients with known or suspected coronary artery disease (CAD).